HWC:NASDAQHancock Whitney Corporation Analysis
Data as of 2026-04-09 - not real-time
$67.01
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Hancock Whitney is trading just above its short‑term moving averages, with momentum indicators pointing to continued upside potential. The RSI sits comfortably in the bullish zone and the MACD histogram is positive, suggesting that recent price action has momentum while the overall trend remains neutral. Valuation metrics show the stock priced well below its discounted cash‑flow estimate and its price‑to‑earnings multiple is notably lower than the regional banking peer average, indicating an attractive entry point. The dividend yield is solid and the payout ratio is comfortably low, supporting the case for sustainable income.
Fundamentally, the company delivers strong operating margins and respectable profitability, with revenue growth outpacing many peers. Balance‑sheet strength is bolstered by ample cash and a manageable debt profile, though the sector faces heightened regulatory scrutiny and the stock exhibits higher‑than‑average volatility and beta, warranting a measured risk approach.
Fundamentally, the company delivers strong operating margins and respectable profitability, with revenue growth outpacing many peers. Balance‑sheet strength is bolstered by ample cash and a manageable debt profile, though the sector faces heightened regulatory scrutiny and the stock exhibits higher‑than‑average volatility and beta, warranting a measured risk approach.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Positive MACD histogram and bullish RSI
- Price near immediate resistance with upside to fair value
- Strong dividend yield and low payout ratio
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Undervaluation relative to DCF and peer PE
- Stable earnings and operating margins
- Moderate sector volatility and regulatory environment
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustainable dividend income
- Long‑term upside to intrinsic fair value
- Robust cash generation and capital position
Key Metrics & Analysis
Financial Health
Revenue Growth6.80%
Profit Margin33.30%
P/E Ratio11.8
ROE11.32%
ROA1.38%
P/B Ratio1.2
Op. Cash Flow$541.8M
Industry P/E17.3
Technical Analysis
TrendNeutral
RSI63.6
Support$59.97
Resistance$67.85
MA 20$63.07
MA 50$66.62
MA 200$62.80
MACDBullish
VolumeDecreasing
Fear & Greed Index83.38
Valuation
Fair Value$75.38
Target Price$76.44
Upside/Downside14.08%
GradeUndervalued
TypeBlend
Dividend Yield2.76%
Risk Assessment
Beta1.17
Volatility27.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.